Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome
Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by a clonal expansion of megakaryocytes. ET can result in both arterial and venous thrombosis. Involvement of the coronary arteries has been reported. Patients who harbor a CALR mutation are half as likely to suffer a thro...
Saved in:
| Main Authors: | Bassel Nazha, Gwenalyn Garcia, Ruben Kandov, Marcel Odaimi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2015/161764 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients
by: Mohamed S. El-Ghonemy, et al.
Published: (2020-01-01) -
Essential thrombocythemia: Busulphan revisited
by: Prasad R Koduri
Published: (2016-01-01) -
The Levels of Adhesion Molecules in Essential Thrombocythemia
by: Oktay Bilgir, et al.
Published: (2014-08-01) -
THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA
by: A. A. Zhernyakova, et al.
Published: (2017-06-01) -
Chilblains as a Clue for the Diagnosis of Essential Thrombocythemia
by: Hugo J. Leme, et al.
Published: (2025-05-01)